BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31951299)

  • 21. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
    Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
    BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA LINC01410 promotes the tumorigenesis of neuroblastoma cells by sponging microRNA-506-3p and modulating WEE1.
    Mi J; Han Y; Zhang J; Hao X; Xing M; Shang C
    Cancer Med; 2020 Nov; 9(21):8133-8143. PubMed ID: 32886453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
    Liu Y; Liu J; Cui J; Zhong R; Sun G
    Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
    Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
    Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
    Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
    Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
    Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression of long non-coding RNA-LINC01410 in pancreatic cancer and its effect on proliferation and migration of pancreatic cancer cells].
    Cai M; Xu L; Shen L; Zhang J
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1406-1411. PubMed ID: 31137129
    [No Abstract]   [Full Text] [Related]  

  • 33. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
    Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
    Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
    Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
    Zhang L; Jiang G; Lu J; Wang L
    Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
    Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
    J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA LINC01410 Suppresses Tumorigenesis and Enhances Radiosensitivity in Neuroblastoma Cells Through Regulating miR-545-3p/HK2 Axis.
    Mou L; Wang L; Zhang S; Wang Q
    Onco Targets Ther; 2021; 14():3225-3238. PubMed ID: 34040388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.